Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
International Journal of Cancer|April 18, 2018
Colony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytesMatthew W Webb, Jianping Sun, Michael A Sheard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2019
Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer CellsHong-Wei Wu, Michael A Sheard, Jemily Malvar, et al.Cancer Research|July 9, 2017
Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal CellsLucia Borriello, Rie Nakata, Michael A Sheard, et al.Journal for Immunotherapy of Cancer|January 11, 2021
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in miceMichael John Zobel, Abigail K Zamora, Hong-Wei Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer CellsHung C Tran, Zesheng Wan, Michael A Sheard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary NeuroblastomaWesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.Journal of Neuro-Oncology|February 11, 2018
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumorsNathan J Robison, Kee Kiat Yeo, Adrian P Berliner, et al.Experimental Cell Research|April 8, 2015
Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentrationMichael A Sheard, Matthew V Ghent, Daniel J Cabral, et al.Scientific Reports|November 14, 2023
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastomaDanny Lascano, Michael J Zobel, William G Lee, et al.Brain : a Journal of Neurology|September 26, 2001
The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodiesH J Willison, C P O'Leary, J Veitch, et al.Pageof 8